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ABSTRACT
Objectives: National and international evidence-based
guidelines for hip and knee osteoarthritis (OA)
recommend to start with non-surgical treatments,
followed by surgical intervention if a patient does not
respond sufficiently to non-surgical treatments, but
there are indications that these are not optimally used.
The aim of this study was to assess the extent to
which all recommended non-surgical treatments were
used by patients with hip or knee OA who receive(d) a
total hip or knee replacement, as reported by patients
and orthopaedic surgeons.
Setting: We performed two cross-sectional internet-
based surveys among patients and orthopaedic
surgeons throughout the Netherlands.
Participants: 195 OA patients either have undergone
total knee arthroplasty or total hip arthroplasty no
longer than 12 months ago or being on the waiting list
for surgery with a confirmed date within 3 months
and 482 orthopaedic surgeons were invited to
participate.
Primary and secondary outcome measures: The
use of recommended non-surgical treatments including
education about OA/treatment options, lifestyle advice,
dietary therapy, physical therapy, acetaminophen,
NSAIDs and glucocorticoid injections.
Results: 174 OA patients (93%) and 172 orthopaedic
surgeons (36%) completed the surveys. Most
recommended non-surgical treatments were given to
the majority of patients (eg, 80% education about OA,
73% physical therapy, 72% acetaminophen, 80%
NSAIDs). However, only 6% of patients and 10% of
orthopaedic surgeons reported using a combination of
all recommended treatments. Dietary therapy was used
least frequently. Only 11% of overweight and 30% of
obese participants reported having received dietary
therapy and 28% of orthopaedic surgeons
reported to prescribe dietary therapy to overweight
patients.
Conclusions: While most recommended
non-surgical treatments were used frequently as
single therapy, the combination is used in only a
small percentage of OA patients. Especially, use of
dietary therapy may be improved to help patients
manage their symptoms, and potentially delay the
need for joint arthroplasty.
INTRODUCTION
Patients with symptomatic hip or knee osteo-
arthritis (OA) suffer from pain and loss of
function for which treatment is required.
Different treatment options are available,
surgical and non-surgical treatments. For
patients, good quality of care is achieved if
their symptoms are managed in the short
term, but also taking into account which
treatment option results in the best long-
term patient outcomes. As the lifespan of a
prosthesis is limited, and patient outcomes
after revision arthroplasty are not as good as
after primary surgery,1 it is generally acknowl-
edged that total hip arthroplasty (THA) and
total knee arthroplasty (TKA) should not be
performed too early. For this reason,
evidence-based guidelines recommend to
start with non-surgical treatments (eg, educa-
tion, physical therapy, non-steroidal anti-
inflammatory drugs (NSAIDs)),2–6 and to
use surgical intervention only if a patient
does not respond sufficiently to non-surgical
treatment options in the context of end stage
OA.7–13 These recommendations are all
based on the large body of evidence support-
ing the effectiveness of these non-surgical
treatments to help patients with hip and
knee OA manage their symptoms and pre-
serve joint function.14
Despite these guidelines, several studies
have suggested that the use of non-surgical
Strengths and limitations of this study
▪ This study assesses the use of non-surgical
treatments in orthopaedic practice, which has
not been done before.
▪ This study includes the perspective of ortho-
paedic surgeons and patients.
▪ Owing to the retrospective nature of our study
and the reliance on self-reported data, it is sus-
ceptible to recall bias.
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treatments in patients with hip or knee OA can be
improved.7 15–18 For instance, Snijders et al7 demon-
strated that 81% of patients with hip or knee OA did not
receive all non-surgical treatments in the primary care
setting. However, patients with OA may receive non-
surgical treatments later on in the care trajectory from
their orthopaedic surgeon once referred to specialist
care. In the Netherlands, patients with OA are usually
treated by the general practitioner. According to guide-
lines, patients should be referred to the orthopaedic
surgeon if they do not respond sufficiently to non-
surgical treatment options. In orthopaedic practice, the
decision will be made to start/continue non-surgical
treatments or to perform a surgery depending on previ-
ous received treatments and disease severity. Therefore,
orthopaedic surgeons have an important role in ensur-
ing optimal care of patients with OA by confirming
whether recommended non-surgical treatments have
been exhaustedly used before considering a surgical
intervention. Furthermore, surgical interventions, like a
THA and TKA do not have good patient reported
outcome in about 10–20% of patients.19–22 This stresses
even more the importance of good non-surgical treat-
ment modalities before implant surgery is encountered.
McHugh et al23 examined which treatments patients with
OA used throughout the care trajectory, before and
while on the waiting list for a TKA or THA, and showed
that only 10% of the patients had received information
on pain management with the consequence that some
patients used their own regime to take analgesics. This
in turn may have led to insufficient effects of analgesics.
However, they did not investigate the full range of non-
surgical treatments and the estimates were reported by
patients, so that the information may have been given to
them but not remembered. Given the known effective-
ness of non-surgical treatments individually and for
some combinations (eg, physical therapy with dietary
therapy24), use of the full range of available recom-
mended non-surgical treatments may improve patient
outcomes,2–6 thereby improving quality of care, and
postpone the need for surgery which would reduce
chances for a revision with worse patient outcomes than
primary surgery. What is currently lacking and needed
to provide a complete view, is an assessment of the full
range of non-surgical treatments as well as including
both patients’ and orthopaedic surgeons’ perspectives,
as these may differ.
Therefore, the aim of this study was to assess the
extent to which all recommended non-surgical treat-
ments were used by patients with hip or knee OA as
reported by patients and orthopaedic surgeons, both as
a single option and in combination.
MATERIALS AND METHODS
Study design
We performed two cross-sectional internet-based surveys in
November and December 2013 and January 2014 to assess
the use of non-surgical treatments in orthopaedic practice
as reported by patients and orthopaedic surgeons.
Population
Patients
A total of 195 patients were invited by email to partici-
pate in the survey, to estimate a previously reported 19%
use of non-surgical treatments among 47 000 patients
with hip and knee OA annually in the Netherlands,25
with a 5% margin of error. Patients were recruited via
advertisements in local newspapers across the
Netherlands, and through the websites or newsletters of
patient associations. Patients who volunteered to partici-
pate in the survey in reaction to the advertisements were
dialed by the research team to provide information
about the study, to answer questions and to ask whether
they approved for participation. In addition, patients
received written information before the start of the
survey and the availability to stop during the study. In
addition, patients received written information before
the start of the survey and the availability to stop during
the study. Inclusion criteria for patients were: age
≥18 years, a doctor’s diagnosis of hip or knee OA, and
either have undergone TKA or THA no longer than
12 months ago or being on the waiting list for surgery
with a confirmed date within 3 months. Patients who
were unable to understand written Dutch or who had
undergone or were scheduled for revision surgery were
excluded from the study. Patients who initially indicated
that they wanted to participate but did not respond,
were sent two reminders, one after one and a half
weeks, and if still no response again after 3 weeks.
Participants who completed the questionnaire received a
€10 gift card as an incentive.
Orthopaedic surgeons
All 482 Dutch orthopaedic surgeons listed in the registry
of the Netherlands Orthopaedic Association (NOV)
and/or the Dutch medical address book with an email
address received an invitation to participate. All ortho-
paedic surgeons who treated patients with hip or knee
OA were eligible. Orthopaedic surgeons who did not
respond received two reminders, one after one and a
half weeks and if still no response again after 3 weeks.




The survey for patients included questions about
general patient characteristics, general health and symp-
toms of OA, and non-surgical treatment for OA. Patient
characteristics included: age, gender, region of residence
(north, middle, and south), educational level (basic edu-
cation (none or only primary education), intermediate
education (prevocational secondary education, senior
secondary vocational training, senior secondary general
education, pre-university education), or high education
2 Hofstede SN, et al. BMJ Open 2015;5:e009117. doi:10.1136/bmjopen-2015-009117
Open Access
(higher professional education or university (bachelor,
master, or PhD degree)), work situation (paid work or
not), height (cm) and weight (kg) to calculate the body
mass index (BMI), and type of insurance (basic and/or
additional coverage for care such as physical therapy,
glucosamine sulfate and hyaluronic acid). Furthermore,
the survey included general and disease-specific health
questions, such as duration of OA and duration of com-
plaints of the affected joint, comorbidities, average pain
during 6 months before surgery, measured on a 0 (no
pain)-10 (unbearable pain) scale, and patient-perceived
reasons for surgery.
Questions about healthcare use included all non-
surgical options before joint replacement surgery as
described in the Dutch stepped-care strategy (SCS) and
were formulated as follows: “Did you receive the follow-
ing treatments for the complaints of your affected joint
before joint replacement surgery?.” The SCS is based on
(inter)national guidelines.26 27 The first step consists of
education, life style advice and acetaminophen. If the
treatment options in the first step are not sufficient,
treatment options in the second step can be considered
(exercise therapy, dietary therapy and NSAIDs).
Multidisciplinary care, intra-articular injections, and
transcutaneous electrical nerve stimulation (TENS) are
treatment options in the third step and could be consid-
ered if treatment options in step one or two are ineffective.
In the survey these non-surgical treatments were formu-
lated as follows: education about the disease OA, educa-
tion about the possible treatment options in OA, lifestyle
advices (ie, stay active, lose weight), physical therapy/
exercise therapy, acetaminophen, anti-inflammatory
painkillers (eg, NSAIDS such as Celebrex, Diclofenac,
Cataflam, Voltaren), tramadol (eg, Tramal, Tramagetic,
Tradonal, Zaldiar), multidisciplinary care (care of differ-
ent healthcare providers at the same time, eg, in a revalid-
ation centre), injections in the knee, TENS (therapy that
uses electrical current on the skin). Patients could
choose one or more of the following answers: yes,
received from the orthopaedic surgeon; yes, received
from another healthcare provider; yes, received on my
own initiative; no.
Survey for orthopaedic surgeons
The survey for orthopaedic surgeons included questions
about their background characteristics, and the prescrip-
tion of non-surgical treatments. Characteristics of ortho-
paedic surgeons included: age, gender, work region,
work setting, years of working experience as an ortho-
paedic surgeon, number of new patients with hip/knee
OA seen per month. Questions about prescribed treat-
ments included all non-surgical options described in the
SCS26 27 and were formulated as follows: “If patients did
not receive the following non-surgical treatments, do
you prescribe these treatments?” In case of physical
therapy or dietary therapy we asked whether they
referred patients, rather than initiating this treatment
themselves. Orthopaedic surgeons could choose one of
the following answers: never, sometimes, often or
(almost) always.
Analysis
Descriptive statistics were used to describe the character-
istics of respondents, and the use of non-surgical treat-
ments from the patients’ or orthopaedic surgeons’
perspectives. From the patient perspective we distin-
guished the use of non-surgical treatments prescribed by
any healthcare provider, by the orthopaedic surgeon, or
undertaken by their own initiative. From the ortho-
paedic surgeon perspective we dichotomised the answers
into ‘prescribed’ (often/almost always) and ‘not pre-
scribed’ (never/sometimes).
To assess the use of non-surgical treatments, we made
a distinction between non-surgical treatments recom-
mended by various organisations (eg, OARSI, EULAR,
AAOS, NOV)14 16 and other non-surgical treatments.
The recommended non-surgical treatments were educa-
tion about OA, education about different treatment
options, lifestyle advice, (referral to) dietary therapy,
physical therapy containing exercises, acetaminophen,
NSAIDs and glucocorticoid injections. Other non-
surgical treatments included glucosamine sulfate, trama-
dol, multidisciplinary care, TENS, and hyaluronic acid
injections (for knee OA). These treatments are not sup-
ported by high quality evidence or clinical guidelines,
but are nevertheless sometimes recommended and used
by patients with OA. BMI of patients was classified into
normal weight if BMI <25 kg/m2, overweight if BMI ≥25
<30 kg/m2, and obese if BMI ≥30 kg/m2 to assess
whether dietary therapy was indicated. If BMI was
unknown, we assumed that dietary therapy was not indi-
cated for that patient.
For each non-surgical treatment, we calculated the per-
centage of patients who had received this treatment, and
the percentage of orthopaedic surgeons who always/
often prescribed this treatment for their patients. In add-
ition, we calculated the percentage of participants who
received/prescribed the recommended non-surgical
treatments listed in each step of the Dutch SCS including
the previous steps (conditional percentage). The propor-
tion of patients and orthopaedic surgeons using each
non-surgical treatment was compared using the χ2 test.
In addition, we explored whether patients and ortho-
paedic surgeons using all recommended treatments dif-
fered from those who did not, in age, gender, region of
residence, BMI and level of education (for patients) and
on differences in age, gender, work region, work setting,
years of working experience and number of new patients
with hip/knee OA seen per month (for orthopaedic sur-
geons). We also explored differences in use of each
treatment between patients with THA and TKA. The
independent t test or Mann Whitney U tests for continu-
ous variables and χ2 tests or Fisher’s exact tests for pro-
portions was used to compare differences between
subgroups. Significance testing was done two-sided at
α=0.05. SPSS V.20.0 was used for analyses.
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Ethics
This study protocol was presented to the Medical Ethical
Committee of the Leiden University Medical Center
(CME P13.087/NV/nv). An exemption was obtained, as
ethical approval for this type of study is not required
under the Dutch law.
RESULTS
Response
A total of 182 patients (response rate of 93%) com-
pleted the survey. Eight patients were subsequently
excluded from the analyses, because they did not fulfil
the inclusion criteria. This left 174 patients (89%)
included in the final analyses.
One hundred and eighty one (response rate of 38%)
orthopaedic surgeons completed the questionnaire.
Nine orthopaedic surgeons were excluded because they
indicated they did not see patients with OA in consulta-
tions. Thus a total of 172 (36%) orthopaedic surgeons
were included in the final analyses.
Characteristics of the population
Patients
Characteristics of patients who completed the question-
naire are described in table 1. The majority of the parti-
cipants were female, 26% were obese (BMI ≥30 kg/m2)
and thus indicated for dietary therapy. Most of the
respondents had already undergone THA or TKA at the
time of recruitment, and a significant proportion of
patients reported a duration of symptoms for more than
5 years. Almost all patients had additional insurance
coverage, meaning that physical and dietary therapy was
likely to be covered by their insurance rather than being
subject to out of pocket expenses.
Orthopaedic surgeons
The characteristics of the orthopaedic surgeons who
completed the questionnaires are presented in table 2.
On average, they had been working for 13 years (SD 8)
as an orthopaedic surgeon, and saw an average of 25
new patients with hip OA (SD 24) and 31 (SD 22) new
patients with knee OA per month. Orthopaedic sur-
geons from various parts of the country and different
hospital types were included in the sample.
Use of recommended non-surgical treatments
Table 3 shows the percentage of patients that received
recommended and non-recommended non-surgical
treatments as reported by patients.
The most frequently received non-surgical treatments
were education about OA (80%), physical therapy
(73%), acetaminophen (72%), education about differ-
ent treatment options (66%) and NSAIDs (64%). Of
these, education about OA and education about differ-
ent treatment options were mostly received from the
orthopaedic surgeon (table 3), whereas the other treat-
ments were received from another healthcare
professional, or patients own initiative. Dietary therapy
was used least frequently, even when non-overweight
patients were excluded. Only 11% of overweight patients
and 30% of the obese patients reported they had
received dietary therapy. A minority of these patients was





Age in years (mean, SD) 64 (7.7)
Female, n (%) 125 (72)
BMI, n (%)
<25 36 (21)
≥25 <30 84 (48)
≥30 46 (26)
Missing 8 (5)
Knee OA, n (%) 94 (54)
Joint replacement (THA or TKA), n (%)
Yes 169 (97)
Within 3 months 5 (3)
First joint replacement, n (%) 132 (73)
Duration of complaints of affected hip/ knee, n (%)
<1 year 13 (8)
1–5 years 86 (49)
6–10 years 42 (24)
11–20 years 25 (14)
>20 years 8 (5)







Cardiovascular disease 12 (7)
Migraine or severe headaches 17 (10)











Paid work, yes n (%) 55 (32)




Living situation, n (%)
Live alone 39 (22)
Live with others 135 (78)
Type of insurance, n (%)
Basic only 4 (2)
Basic with additional coverage 170 (98)
*Average pain during 6 months before surgery measured on a 0
(no pain)-10 (unbearable pain) scale.
BMI, body mass index; OA, osteoarthritis; THA, total hip
arthroplasty; TKA, total knee arthroplasty.
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referred to a dietician by their orthopaedic surgeon
(table 3).
In addition, looking at the conditional percentage in
table 4, only 33% of the patients received all recom-
mended treatments in step 1 of the SCS, and eleven
(6%) patients reported to have received all recom-
mended treatments in step 1 and 2 of the SCS. Because
many patients did not remember which type of injection
they received, we excluded glucocorticoid injections and
did not calculated the conditional percentage of step 1,
2 and 3 together.
Reasons for surgery according to patients (multiple
answers possible) were: pain could not be controlled
with painkillers (55% of the patients), insufficient effect
of other treatments (eg, physical therapy, dietary advice)
(51%), duration of symptoms (41%), difficulties with
daily activities (75%), or other reasons (17%) (eg,
severe cartilage loss, difficulties with sports, immobility).
Table 5 shows the percentage of orthopaedic surgeons
that often or always prescribes recommended non-
surgical treatments as reported by orthopaedic surgeons.
Orthopaedic surgeons often reported to prescribe life-
style advice (98%), education about different treatment
options (95%), education about OA (87%) and acet-
aminophen (64%). However, table 6 shows that only 96
(56%) of the orthopaedic surgeons reported prescribing
all recommended treatments in step 1 of the SCS, 17
(10%) reported prescribing all recommended treat-
ments in step 1 and 2, and 10 (6%) reported prescribing
all recommended treatments in step 1, 2 and 3, if the
patient had not received these treatments in their previ-
ous care trajectory. As among patients, dietary therapy
was reported as the least prescribed treatment (reported
by 28% of the orthopaedic surgeons), followed by
intra-articular injections (43%) and physical therapy
(54%).
Table 2 Characteristics of orthopaedic surgeons who




Age in years, mean (SD) 48.4 (8.6)
Female, n (%) 16 (9%)
Years working as an orthopaedic
surgeon; mean (SD)
12.8 (8.0)
New patients with primary hip OA
seen per month; mean (SD)
25.1 (22.2)
New patients with primary knee
OA seen per month; mean (SD)
31.3 (23.9)





General hospital 89 (52)
University medical centre 13 (8)
Private clinic 20 (12)
Teaching hospital 54 (31)
Other 7 (4)
*Multiple options possible, so the sum of percentages may be
larger than 100%.
OA, osteoarthritis.











Education about OA 139 (80) 95 (68) 30 (22) 31 (22)
Education about different
treatment options
115 (66) 80 (70) 27 (23) 21 (18)
Lifestyle advice 107 (62) 37 (35) 40 (37) 40 (37)
Dietary therapy, if indicated
BMI ≥25 <30 9 (11) 2 (22) 3 (33) 5 (56)
BMI ≥30 14 (30) 1 (7) 7 (50) 6 (43)
Physical therapy 127 (73) 33 (26) 70 (55) 36 (28)
Contained exercises 116 (91)
Acetaminophen 125 (72) 26 (21) 30 (24) 73 (58)
NSAIDs 111 (64) 43 (39) 51 (46) 19 (17)
Tramadol 44 (25) 21 (48) 24 (55) 1 (2)
Glucosamine sulfate 58 (33) 7 (12) 9 (16) 46 (79)
Multidisciplinary care 12 (7) 4 (33) 8 (67) 1 (8)
TENS 10 (6) 0 10 (100) 0
Intra-articular injections
(knee OA n=94)
54 (57) 46 (85) 12 (22) 0
Glucocorticoid 28 (30)
Hyaluronic acid 7 (7)
Unknown 20 (37)
*Multiple options possible, thus the sum of orthopaedic surgeon, other healthcare professional and own initiative can be >100%.
BMI, body mass index; NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis; TENS, transcutaneous electrical nerve stimulation.
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No differences were found between patients receiving
and not receiving all recommended non-surgical treat-
ments in any of the patient characteristics tested.
Similarly, no differences were found between ortho-
paedic surgeons prescribing and not prescribing all
recommended non-surgical treatments in any of their
characteristics. Patients with knee OA received acet-
aminophen more often than patients with hip OA (80%
vs 63% respectively (p=0.01)), but no differences were
found in the use of other treatments. Furthermore, com-
paring patients and orthopaedic surgeons, no differ-
ences were found in the proportion using education
about OA (p=0.09), acetaminophen (p=0.18), NSAIDs
(p=0.39), and the percentage using all recommended
non-surgical treatments (p=0.22). A smaller percentage
of patients compared to orthopaedic surgeons reported
having received/prescribed education about different
treatment options (p<0.001), lifestyle advice (p<0.001)
and dietary therapy (p=0.03). The use of physical
therapy on the other hand was reported to have been
received by more patients than being prescribed by
orthopaedic surgeons (73% vs 54% (p<0.001)).
Use of other non-surgical treatments
Glucosamine sulfate was the most frequently used other
non-surgical treatment, reported by 33% of patients,
and mostly (79%) used on their own initiative.
Multidisciplinary care (7%) and TENS (6%) were the
least often reported other treatments. Thirty-three per
cent of the patients who received multidisciplinary care
were referred by their orthopaedic surgeon, and none
of the patients who used TENS was referred by their
orthopaedic surgeon. Overall, orthopaedic surgeons
rarely prescribed any of these treatments not recom-
mended by published OA guidelines, the highest per-
centage (8%) was for the recommendation of
glucosamine sulfate.
DISCUSSION
Our study showed that although most recommended
non-surgical treatments seem to be frequently used as a
single option in OA patients who receive(d) a THA or
TKA, only a small percentage of patients received all
recommended non-surgical treatments. For that matter,
only 6% of patients and 10% of orthopaedic surgeons
reported using all recommended non-surgical treat-
ments in step 1 and 2 of the SCS.27 Given the known
effectiveness of each of these treatments individually, use
of the full range of available modalities may improve
patient outcomes.2–6
Dietary therapy was the least frequently used recom-
mended non-surgical treatment for OA. Only 11% of
overweight patients and 30% of obese patients reported
having received dietary therapy, and only 28% of ortho-
paedic surgeons reported they would prescribe dietary
therapy. Another study in the Netherlands showed that
only 14% of overweight and obese patients with OA
reported receiving dietary therapy.16 This is even lower
than reported in our study, but these patients were
recruited by general practitioners, and thus may have
subsequently received dietary therapy later on in the
care trajectory for example, after referral to an ortho-
paedic surgeon. In our study, patients had visited mul-
tiple healthcare providers, potentially increasing the
likelihood of being offered dietary therapy when indi-
cated. In other countries, dietary therapy seems to be
more commonly used, for example, 59% of physicians
prescribed ‘weight reduction’ in a study performed in
France,13 and 31% of patients with OA in a study in
Canada.17 Although the numbers are higher, the overall
low rates across studies suggest that there is room for
improvement. Similarly, a considerable number of
patients were not prescribed physical therapy. The use of
physical therapy as a non-surgical treatment could even
be overestimated, because orthopaedic surgeons
Table 4 Conditional percentage of patients receiving recommended non-surgical treatments in stepped care strategy as
reported by patients
Recommended non-surgical treatments in stepped care strategy Conditional n (%)
Step 1: education about OA+education about different treatment options+lifestyle advice+acetaminophen 57 (33)
Step 1+2: step 1+(Referral to) dietary therapy, when indicated+physical therapy+NSAIDs 11 (6)
Step 1, 2+3: step 1+2+intra-articular injections (for knee OA n=94) n/c
n/c: not calculated, because many patients did not know which type of injection they received.
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
Table 5 Prescribed recommended non-surgical








Education about OA 149 (87)
Education about different treatment options 163 (95)
Lifestyle advice 168 (98)
(Referral to) dietary therapy, when
indicated
49 (28)
Physical therapy 93 (54)
Acetaminophen 112 (64)
NSAIDs 102 (59)
Intra-articular injections 74 (43)
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
6 Hofstede SN, et al. BMJ Open 2015;5:e009117. doi:10.1136/bmjopen-2015-009117
Open Access
sometimes prescribe physical therapy as preparation
before surgery instead of a non-surgical treatment to
delay surgery. Dietary therapy and physical therapy are
the only two recommended non-surgical treatments that
an orthopaedic surgeon cannot provide himself, but for
which referral is needed. Improving the use of these two
treatments in orthopaedic care, may result in better
quality of patient care as the combination of weight loss
plus exercise is shown to provide better overall improve-
ments in function, pain and mobility among older over-
weight and obese adults with knee OA compared with
either intervention alone.24
This study has some limitations. First, because of the
retrospective nature of our study and the reliance on
self-reported data, it is susceptible to recall bias. In an
attempt to reduce this bias, we limited inclusion to
patients who had a TKA or THA no longer than
12 months ago, or were scheduled for surgery within the
next 3 months. Second, the use of an internet-based
survey could induce selection bias. It is known that the
majority of THA and TKA patients prefer pen-and-paper
questionnaires, and that patients who prefer electronic
questionnaires differ from patients who prefer
pen-and-paper questionnaires.28 It is possible that more
elderly persons do not have internet or an email address
compared to younger persons, which could have led to a
selection of younger persons. The average age of
patients with OA is 68.2 years29 and our population is
slightly younger, on average 64 (SD 7.7) years. However,
age was not associated with the use of all recommended
non-surgical treatments. Third, the use of a sample of
patients responding to an advertisement may have intro-
duced sampling bias. However, as our responding
patients were distributed across different regions in the
Netherlands, and had an age and gender distribution
comparable to OA patients, we think that any bias that
may have occurred is likely to be small. Similarly, selec-
tion bias may have occurred as a result of the low
response rate (38%) among orthopaedic surgeons.
However, such a response rate is comparable or higher
than found in other online surveys among orthopaedic
surgeons in the Netherlands.30 31 It is possible that
orthopaedic surgeons who are not interested in non-
surgical treatment were less likely to complete the ques-
tionnaire or that orthopaedic surgeons overestimate
their use of non-surgical treatments. This would only
lead to an overestimation of non-surgical treatment use
and the use may be even lower. Furthermore, the use of
acetaminophen, NSAIDs and tramadol could have been
overestimated, as we were not able to define a minimum
for the use of these treatments (eg, at least 1 tablet per
day) due to differences between recommendations.
Therefore, we simply reported whether patients took
acetaminophen or NSAIDs (yes/ no) without any
minimum dose. However, in some cases the use was less
than multiple days per month (4% for acetaminophen
and 5% for NSAIDs, results not shown). In addition, 57
patients (33%) suffered from hypertension and 12 (7%)
from cardiovascular diseases, both of which are contrain-
dications to NSAIDs use.6 This may have resulted in
underestimating the use of NSAIDs or Tramadol, as
these patients should be excluded from these estimates.
To our knowledge this is the first study that evaluated
the full range of combinations of non-surgical treat-
ments for OA, both from the perspective of orthopaedic
surgeons and patients. While most recommended non-
surgical treatments for OA were used frequently as
single therapy, the combination is used in only a small
percentage of OA patients who receive(d) a THA or
TKA. Despite their potential for reducing symptoms of
knee and hip OA, dietary therapy and physical therapy
appear to be least frequently used. By increasing the use
of these two non-surgical treatments, primary care physi-
cians and orthopaedic surgeons may be able to help
patients better manage their symptoms, thereby improv-
ing quality of care and potentially postpone the need for
joint arthroplasty, resulting in improved long-term
patient outcomes. Future studies should focus on evalu-
ating the reasons (barriers) why some orthopaedic
surgeons do not use recommended non-surgical treat-
ments. Such findings may be helpful in developing tar-
geted strategies to improve the use of these treatments
in orthopaedic practice and thereby to improve quality
of care. Although the recommended non-surgical treat-
ment options have been proven to be effective individu-
ally or in combination (eg, physical therapy with dietary
therapy24), there are no published studies that investi-
gated the combined effect of all of these treatments.
Nevertheless, it has been hypothesised that optimised
non-surgical treatment could result in significantly
Table 6 Conditional percentage of orthopaedic surgeons who prescribe recommended non-surgical treatments in stepped
care strategy
Recommended non-surgical treatments
in stepped care strategy
Conditional
n (%)
Step 1: education about OA+education about different treatment options+lifestyle advice
+acetaminophen
96 (56)
Step 1+2: step 1+(referral to) dietary therapy, when indicated+physical therapy+NSAIDs 17 (10)
Step 1, 2+3: step 1+2+intra-articular injections (for knee OA n=94) 10 (6)
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
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greater pain reduction, functional improvement and
increase in quality of life than usual care in knee OA.32
The results from the present study suggest that such
better outcomes may be achieved in a considerable part
of OA patients.
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